US FDA's recent approval of Endomagnetics Ltd. 's Magtrace and Sentimag Magnetic Localization System is a case study of how the agency's new Oncology Center for Excellence is helping coordinate h
Now that the US FDA has approved its Magtrace non-radioactive breast cancer tracer for its Sentimag magnetic localization system, Endomag has big plans to scale its commercial operations. The UK